NCT00211601View on ClinicalTrials.gov

Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Chemotherapy Induced Nausea and Vomiting
Interventions
BEHAVIORAL

Disease Management Assessment

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00211601 - Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041) | Biotech Hunter | Biotech Hunter